Products

FineChat.ai

AI-native

Chat GPT4o Free Online Access

finechat.ai AI Models & Agents / General AI Assistants

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Launched
3y ago
2023-09-16 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on V2EX (3 thanks · 32 comments)Launch

    新的 Claude 2 镜像站上线了,依然免费,欢迎使用和传播 — 之前做过一个镜像站,大家还挺喜欢的,但是后来因为域名和官网太像,被迫下线了。 沉寂了一段时间以后还是不太甘心,就又上线了一个新的镜像站: ,还是和之前一样,能够提供和官网一样的 Claude 2 对话服务,支持 100K 上下文、和文档对话这些能力都不在话下,大家应该都熟悉,…

    Sep 26, 2023 · 3y agoLaunch page

  • Launched on 阮一峰周刊投稿 (1 comments)Launch

    【工具自荐】新Claude 2镜像站上线了 — Claude 2被称为ChatGPT最强劲的竞争对手,支持100K上下文对话,并且可以同时和5个文档进行对话。使用流畅,且语言和逻辑推理能力仅次于GPT4。 但是Claude2目前只开放给美国和英国的节点使用,所以我们做了一个国内镜像站:https://finechat.ai ,最大的特点是: 和官网体验完全一致,包括对话能力、文档处理能力以及前端界面; 国内可以方便使用,不需要梯子; 只需要邮箱验证码即可(和官网一样)。 镜像站地址:https://finechat.ai 希望阮老师能采纳。

    Sep 16, 2023 · 3y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2023-09-08

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Website snapshots

Indexed 2026-07-31

Key pages

Desktop & mobile archive
finechat.ai/ Snapshot 2026-11-16

Questions & evidence

How much website traffic does FineChat.ai get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is FineChat.ai and what platforms does it support?
FineChat.ai is catalogued under General AI Assistants: Chat GPT4o Free Online Access. Supported platforms: Web.

Related products in this category

AI Models & Agents / General AI Assistants

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.